First of all, sending so much strength your way β what a year you've been through, and yet here you are, showing up and fighting. That takes real courage. πͺπ»
Elahere (mirvetuximab soravtansine-gynx) was specifically approved for platinum-resistant ovarian cancer that tests positive for folate receptor-alpha, so it sounds Show Full Answer
First of all, sending so much strength your way β what a year you've been through, and yet here you are, showing up and fighting. That takes real courage. πͺπ»
Elahere (mirvetuximab soravtansine-gynx) was specifically approved for platinum-resistant ovarian cancer that tests positive for folate receptor-alpha, so it sounds like your oncology team has matched you with the right tool for this moment. Here's what is generally known about Elahere's side effects, so you can feel prepared going in:
- Eye-related issues β irritation, blurry vision, and dry eyes are among the most commonly reported
- Fatigue β tiredness is common, so rest when your body asks for it
- Nausea β manageable for many, especially with anti-nausea medication
- Stomach discomfort β mild GI symptoms have been reported
It's given by IV infusion every three weeks, which many people find a manageable schedule. A few practical tips that MyOvarianCancerTeam members have found helpful when managing treatment side effects in general:
- For nausea β smaller, more frequent meals and avoiding spicy or fatty foods can help
- For fatigue β gentle movement when possible, and prioritizing sleep
- For eye symptoms β ask your care team about eye drops before your first infusion, as some centers proactively manage this
The most important thing is to keep your oncology team informed about every symptom you experience, no matter how small it seems. Early reporting means faster relief. ππ»
July 23